Stéphane Bancel (#2254)
- $ 2 B
- Biotech, vaccines
- France
- M
- 53 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Stephane Bancel is the CEO of Cambridge, Massachusetts-based biotech firm Moderna, known for its Covid-19 vaccine. He became CEO of Moderna in 2011 and owns a roughly 5.5% stake in the publicly traded company. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMerieux, founded by fellow French billionaire Alain Merieux. Moderna's Covid-19 vaccine was granted full FDA approval in January 2022; it had previously received emergency-use authorization in December 2020. Moderna was founded in 2010 and went public in December 2018; the company develops drugs and vaccines using messenger RNA.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Stéphane Bancel’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Stéphane Bancel’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.8B
(May 4, 2026)
© Iconic Billionaires